Abstract

The clinical spectrum of acute myocardial infarction (MI) may alter from ST elevation MI (STEMI) to non-ST elevation MI (NSTEMI) or unstable angina. It has commonly been suggested that early coronary artery bypass surgery (CABG) after acute MI may be associated with increased morbidity and mortality. However, advances in technology, surgical methods and myocardial protection techniques provide a chance for cardiovascular surgeon to achieve treatment of all these clinical scenarios [1]. We read with great interest the paper by Dayan and colleagues [2]. The authors have attempted to seek the answers to an important question: Does early CABG improve survival in NSTEMI? They concluded that CABG may be safely performed in patients with NSTEMI at any time after the first 6 h of MI in patients with cTnI <0.15 ng/ml. We fully agree with their implications regarding this subject and would also like to add a short comment. Patients with NSTEMI represent a heterogeneous group and are subject to a significant risk of adverse cardiac events. Early risk stratification is essential to identify patients at highest risk. CABG for complete revascularization may be frequently put into practice as a therapeutic option in patients with NSTEMI. Therefore, cardiac surgeons are faced with the difficult decision of determining the optimal surgical timing in clinically stable patients. Various studies have been designed to inform us about the risk of CABG according to the time elapsed from the event. Practice guidelines recommend delaying CABG for a few days after index admission in STEMI patients to minimize risk. However, the optimal surgical timing after the event is not addressed in most recent guidelines for NSTEMI patients. There is no consensus as to which acute MI classification poses a greater risk after CABG. Recently, Zhang and colleagues [3] studied 2412 patients who underwent isolated CABG within 21 days after acute MI. The authors suggested that MI subtype (STEMI vs NSTEMI) did not predict in-hospital mortality or major adverse events. The GRACE (Global Registry of Acute Coronary Events) score is an easily applicable and validated tool to aid the decision-making process in patients with NSTEMI. Senanayake and colleagues [4] compared the outcomes of patients undergoing urgent CABG after 24 h of NSTEMI with the GRACE predicted in-hospital and 6-month survival. In their study, urgent CABG was associated with in-hospital mortality and 6-month survival superior to that predicted by the GRACE risk score in all risk groups. The impact of early or deferred CABG on clinical outcomes of NSTEMI has not been well established. Zhang and colleagues [5] conducted a systematic literature search. In their meta-analysis, early CABG was not superior to deferred CABG for the prevention of all-cause death in patients with NSTEMI. However, a significant decrease in refractory ischaemia was observed in the early CABG patients, and the procedure also showed a tendency toward decreasing major bleeding events. In our opinion, early CABG may be performed with favourable results when the surgical timing and selected subset of patients with NSTEMI are appropriate. Conflict of interest: none declared.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call